PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $78.10 million. The enterprise value is $24.26 million.
| Market Cap | 78.10M |
| Enterprise Value | 24.26M |
Important Dates
The next estimated earnings date is Monday, July 29, 2024, after market close.
| Earnings Date | Jul 29, 2024 |
| Ex-Dividend Date | Aug 11, 2023 |
Share Statistics
PetMed Express has 20.61 million shares outstanding. The number of shares has increased by 0.28% in one year.
| Shares Outstanding | 20.61M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 4.21% |
| Owned by Institutions (%) | 73.52% |
| Float | 17.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 17.92 |
| PS Ratio | 0.28 |
| Forward PS | 0.28 |
| PB Ratio | 0.81 |
| P/FCF Ratio | n/a |
| PEG Ratio | 2.58 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.09 |
| EV / EBITDA | 89.18 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.30 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 5.35 |
| Debt / FCF | n/a |
| Interest Coverage | 13.28 |
Financial Efficiency
Return on equity (ROE) is -7.20% and return on invested capital (ROIC) is -8.31%.
| Return on Equity (ROE) | -7.20% |
| Return on Assets (ROA) | -4.30% |
| Return on Capital (ROIC) | -8.31% |
| Revenue Per Employee | $979,317 |
| Profits Per Employee | -$26,007 |
| Employee Count | 287 |
| Asset Turnover | 1.64 |
| Inventory Turnover | 8.51 |
Taxes
In the past 12 months, PetMed Express has paid $1.19 million in taxes.
| Income Tax | 1.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.08% in the last 52 weeks. The beta is 0.73, so PetMed Express's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -73.08% |
| 50-Day Moving Average | 4.17 |
| 200-Day Moving Average | 5.92 |
| Relative Strength Index (RSI) | 42.99 |
| Average Volume (20 Days) | 495,746 |
Short Selling Information
The latest short interest is 3.15 million, so 15.27% of the outstanding shares have been sold short.
| Short Interest | 3.15M |
| Short Previous Month | 3.04M |
| Short % of Shares Out | 15.27% |
| Short % of Float | 17.53% |
| Short Ratio (days to cover) | 5.72 |
Income Statement
In the last 12 months, PetMed Express had revenue of $281.06 million and -$7.46 million in losses. Loss per share was -$0.37.
| Revenue | 281.06M |
| Gross Profit | 78.65M |
| Operating Income | -8.16M |
| Pretax Income | -6.27M |
| Net Income | -7.46M |
| EBITDA | 272,000 |
| EBIT | -6.78M |
| Loss Per Share | -$0.37 |
Balance Sheet
The company has $55.30 million in cash and $1.45 million in debt, giving a net cash position of $53.84 million or $2.61 per share.
| Cash & Cash Equivalents | 55.30M |
| Total Debt | 1.45M |
| Net Cash | 53.84M |
| Net Cash Per Share | $2.61 |
| Equity (Book Value) | 96.73M |
| Book Value Per Share | 4.69 |
| Working Capital | 21.49M |
Cash Flow
In the last 12 months, operating cash flow was $4.32 million and capital expenditures -$4.51 million, giving a free cash flow of -$194,000.
| Operating Cash Flow | 4.32M |
| Capital Expenditures | -4.51M |
| Free Cash Flow | -194,000 |
| FCF Per Share | -$0.01 |
Margins
Gross margin is 27.98%, with operating and profit margins of -2.90% and -2.66%.
| Gross Margin | 27.98% |
| Operating Margin | -2.90% |
| Pretax Margin | -2.23% |
| Profit Margin | -2.66% |
| EBITDA Margin | 0.10% |
| EBIT Margin | -2.41% |
| FCF Margin | -0.07% |
Dividends & Yields
This stock pays an annual dividend of $0.30, which amounts to a dividend yield of 7.92%.
| Dividend Per Share | $0.30 |
| Dividend Yield | 7.92% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.28% |
| Shareholder Yield | 7.64% |
| Earnings Yield | -9.56% |
| FCF Yield | -0.25% |
Analyst Forecast
The average price target for PetMed Express is $5.25, which is 38.52% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.25 |
| Price Target Difference | 38.52% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 2.9 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.9 |
| Piotroski F-Score | 4 |